Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Impact of the Use of the Digital Solution NewSpringForMe on Transplanted Patients' Quality of Life and Support (Bone Marrow or Peripheral Stem Cells Allotransplantation)

NCT06148610 is registered in ClinicalTrials.gov with Fonds de Dotation HTC Project as lead sponsor.

NCT NCT06148610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06148610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Impact of the Use of the Digital Solution NewSpringForMe on Transplanted Patients' Quality of Life and Support (Bone Marrow or Peripheral Stem Cells Allotransplantation)
Lead sponsor
Fonds de Dotation HTC Project
Phase
Observational
Overall status
Unknown status
Start date
September 27, 2022
Completion date
December 31, 2024
Enrollment
170 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplantation, hematologic diseases, hematopoietic stem cell transplantation